GTHX earnings call for the period ending June 30, 2019.
News & Analysis: G1 Therapeutics, Inc.
These stocks were huge winners last week. But can their momentum continue?
Favorable comments from analysts helped some of these power players stand out on a strong day for the market.
GTHX earnings call for the period ending March 31, 2019.
The clinical-stage biopharmaceutical company is on track to file for FDA approval of its first drug, trilaciclib.
GTHX earnings call for the period ending December 31, 2018.
Investors rushed out of the stock following disappointing trial data.
These highfliers could could climb higher. Here's what needs to happen.